Registered Kenya · PPB

NEOCURON

PANCRONIUM BROMIDE

What it does

Pancronium is a medication used to relax muscles during surgery or mechanical ventilation.

Commonly used for: muscle relaxation during surgery, muscle relaxation for patients on a ventilator

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
21513
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
PANCRONIUM BROMIDE
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Ripple Pharmaceuticals
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
Swaminarayan Road/ Laxcon Court Mezzanine, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 22:00:31 · updated 2026-03-23 04:45:39

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Pancronium is a medication used to relax muscles during surgery or mechanical ventilation.

What it treats

  • muscle relaxation during surgery
  • muscle relaxation for patients on a ventilator

How it works

Pancronium works by blocking nerve signals to the muscles, causing them to relax.

Who it's for

It is used for patients undergoing surgery or those who need help breathing with a ventilator.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: pancronium

Pancuronium is a neuromuscular blocker used primarily as an adjunct to general anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is classified as a non-depolarizing muscle relaxant, acting as an antagonist at the neuromuscular junction.

Indications

  • Facilitation of endotracheal intubation
  • Muscle relaxation during surgical procedures
  • Adjuvant therapy in mechanical ventilation

Dosage

Children: Pediatric dosing should be carefully determined based on age, weight, and clinical condition. Consult the BNF for Children for specific dosing information.

Adults: Dosage varies based on the clinical situation and should be determined by the healthcare provider. Refer to clinical guidelines for specific dosing recommendations.

Mechanism of action

Pancuronium works by competitively inhibiting acetylcholine at the motor end plate, preventing the binding of acetylcholine to nicotinic receptors on the skeletal muscle. This blockade inhibits the transmission of nerve impulses to the muscle, resulting in paralysis. It does not cause depolarization of the muscle membrane and requires reversal after its effects are no longer needed.

Pharmacodynamics

The onset of action for pancuronium is generally within 2 to 3 minutes, with peak effects occurring around 10 to 15 minutes after administration. The duration of action can vary from 30 to 120 minutes, depending on the dose and individual patient factors. Pancuronium can cause cardiovascular effects, such as increased heart rate, due to its vagolytic properties.

Pharmacokinetics

Pancuronium is administered intravenously and is widely distributed in body tissues. It is metabolized primarily by the liver, and its metabolites are excreted in urine. The half-life of pancuronium is approximately 1 to 2 hours in healthy adults. Renal impairment may prolong the duration of action due to decreased clearance.

Contra-indications

  • Hypersensitivity to pancuronium or any of its components
  • Myasthenia gravis
  • Severe obesity

Adverse effects

  • Prolonged neuromuscular blockade
  • Respiratory depression
  • Hypotension
  • Tachycardia
  • Increased heart rate
  • Allergic reactions

Interactions

  • Aminoglycoside antibiotics may potentiate the neuromuscular blockade
  • Calcium channel blockers may enhance the effects of pancuronium
  • Anesthetics may interact and alter neuromuscular function

Precautions

  • Use with caution in patients with cardiovascular disease
  • Monitor respiratory function closely during and after administration
  • Caution in patients with liver or kidney impairment

Pregnancy

Pancuronium should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Safety in pregnancy has not been established.

Breast-feeding

Pancuronium is excreted in breast milk, caution should be exercised when administered to nursing mothers.

Storage

Store in a cool, dry place, protected from light. Keep out of reach of children.

Formulations

  • Injection: 1 mg/mL solution for injection

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.